Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis

Hepatology

Volumn 47, Issue 3, 2008, Pages 978-985

  Francés, Rubén ^a,b   Zapater, Pedro ^a,b   González Navajas, José M ^a,b   Muñoz, Carlos ^b   Caño, Rocío ^b   Moreu, Rocío ^b   Pascual, Sonia ^a,b   Bellot, Pablo ^b   Pérez Mateo, Miguel ^b   Such, José ^a,b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; NITRIC OXIDE; NORFLOXACIN; RNA 16S; TUMOR NECROSIS FACTOR ALPHA; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; ASCITES; ASCITES FLUID; BACTERIAL GENOME; BACTERIAL INFECTION; BACTERIAL PERITONITIS; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIGITALIZATION; DNA DETERMINATION; DNA TRANSFER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE AMPLIFICATION; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; METABOLITE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RNA SEQUENCE; BLOOD; DRUG ANTAGONISM; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PERITONITIS;

ADULT; AGED; ANTI-BACTERIAL AGENTS; ASCITES; BACTERIAL INFECTIONS; DNA, BACTERIAL; FEMALE; HUMANS; IMMUNITY, NATURAL; INTERFERON TYPE II; INTERLEUKIN-12; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NORFLOXACIN; PERITONITIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 40949083014     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22083     Document Type: Article

References (20)

1. Guarner C, Soriano G. Spontaneous bacterial peritonitis. Semin Liver Dis 1997;17:203-217.
2. Such J, Runyon BA. Spontaneous bacterial peritonitis. Clin Infect Dis 1998;27:669-674.
3. Garcia-Tsao G. Bacterial translocation: cause or consequence of decompensation in cirrhosis? J Hepatol 2001;34:150-155.
4. Wiest R, Garcia-Tsao G. Bacterial translocation (BT) in cirrhosis. HEPATOLOGY 2005;41:422-433.
5. Berg RD. Bacterial translocation from the gastrointestinal tract. J Med 1992;23:217-244.
6. Frances R, Munoz C, Zapater P, Uceda F, Gascon I, Pascual S, et al. Bacterial DNA activates cell mediated immune response and nitric oxide overproduction in peritoneal macrophages from patients with cirrhosis and ascites. Gut 2004;53:860-864.
7. Such J, Hillebrand DJ, Guarner C, Berk L, Zapater P, Westengard J, et al. Tumor necrosis factor-alpha, interleukin-6, and nitric oxide in sterile ascitic fluid and serum from patients with cirrhosis who subsequently develop ascitic fluid infection. Dig Dis Sci 2001;46:2360-2366.
8. Guarner C, Soriano G, Tomas A, Bulbena O, Novella MT, Balanzo J, et al. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. HEPATOLOGY 1993;18:1139-1143.
9. Frances R, Gonzalez-Navajas JM, Zapater P, Munoz C, Cano R, Pascual S, et al. Bacterial DNA induces the complement system activation in serum and ascitic fluid from patients with advanced cirrhosis. J Clin Immunol 2007;27:438-444.
10. Runyon BA, Antillon MR, Akriviadis EA, McHutchison JG. Bedside inoculation of blood culture bottles with ascitic fluid is superior to delayed inoculation in the detection of spontaneous bacterial peritonitis. J Clin Microbiol 1990;28:2811-2812.
11. Such J, Frances R, Munoz C, Zapater P, Casellas JA, Cifuentes A, et al. Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites. HEPATOLOGY 2002;36:135-141.
12. Wennmalm A, Benthin G, Petersson AS. Dependence of the metabolism of nitric oxide (NO) in healthy human whole blood on the oxygenation of its red cell haemoglobin. Br J Pharmacol 1992;106:507-508.
13. Albillos A, de la Hera A, Alvarez-Mon M. Serum lipopolysaccharide-binding protein prediction of severe bacterial infection in cirrhotic patients with ascites. Lancet 2004;363:1608-1610.
14. Krieg AM. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 2002;20:709-760.
15. Lipford GB, Sparwasser T, Bauer M, Zimmermann S, Koch ES, Heeg K, et al. Immunostimulatory DNA: sequence-dependent production of potentially harmful or useful cytokines. Eur J Immunol 1997;27:3420-3426.
16. Fernandez J, Navasa M, Planas R, Montoliu S, Monfort D, Soriano G, et al. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology 2007; 133:818-824.
17. Aparicio JR, Such J, Pascual S, Arroyo A, Plazas J, Girona E, et al. Development of quinolone-tesistant strains of Escherichia coli in stools of patients with cirrhosis undergoing norfloxacin prophylaxis: clinical consequences. J Hepatol 1999;31:277-283.
18. Ortiz J, Vila MC, Soriano G, Minana J, Gana J, Mirelis B, et al. Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients. HEPATOLOGY 1999;29:1064-1069.
19. Garcia-Tsao G, Angulo P, Garcia JC, Groszmann RJ, Cadelina GW. The diagnostic and predictive value of ascites nitric oxide levels in patients with spontaneous bacterial peritonitis. HEPATOLOGY 1998;28:17-21.
20. Hary L, Andrejak M, Leleu S, Orfila J, Capron JP. The pharmacokinetics of ceftriaxone and cefotaxime in cirrhotic patients with ascites. Eur J Clin Pharmacol 1989;36:613-616.